Soleno Therapeutics, Inc. (SLNO) financial statements (2021 and earlier)

Company profile

Business Address 1235 RADIO ROAD
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments49212317358
Cash and cash equivalents49212317358
Restricted cash and investments   0000
Receivables  0 00 
Inventory, net of allowances, customer advances and progress billings    110
Inventory    110
Other undisclosed current assets1021000
Total current assets:50212518468
Noncurrent Assets
Finance lease, right-of-use asset00
Operating lease, right-of-use asset00
Property, plant and equipment0000000
Intangible assets, net (including goodwill)1517182011 
Goodwill    11 
Intangible assets, net (excluding goodwill)1517182000 
Other noncurrent assets 0 011 
Other undisclosed noncurrent assets   0   
Total noncurrent assets:15171821220
TOTAL ASSETS:65384339688
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4211111
Accounts payable3211111
Employee-related liabilities10     
Debt00    0
Derivative instruments and hedges, liabilities     1 
Disposal group, including discontinued operation   0   
Other liabilities00     
Other undisclosed current liabilities4211120
Total current liabilities:9522231
Noncurrent Liabilities
Long-term debt and lease obligation 0     
Finance lease, liability 0
Operating lease, liability 0
Liabilities, other than long-term debt 041000 
Deferred tax liabilities, net44   
Disposal group, including discontinued operation, liabilities   0   
Other liabilities 0 000 
Business combination, contingent consideration, liability   5   
Other undisclosed noncurrent liabilities1118710  
Total noncurrent liabilities:1118111100 
Total liabilities:19231312231
Stockholders' equity
Stockholders' equity attributable to parent, including:4615302733(10)
Common stock0000000
Additional paid in capital2281731571401028961
Accumulated deficit(182)(158)(127)(114)(98)(86)(71)
Other undisclosed stockholders' equity attributable to parent   000 
Total stockholders' equity:4615302733(10)
Other undisclosed liabilities and equity     217
TOTAL LIABILITIES AND EQUITY:65384339688

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 0  11 
Revenue, net 11 
Sublease income 0
Cost of revenue    (2)(0) 
Gross profit: 0  (0)0 
Operating expenses(36)(23)(14)(12)(14)(12)(5)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
   (1)   
Other undisclosed operating income (loss) (0) 1   
Operating loss:(36)(23)(14)(12)(14)(12)(5)
Nonoperating income (expense)12(7)2(2)2 (3)
Investment income, nonoperating  2   0
Debt instrument, convertible, beneficial conversion feature      2
Other nonoperating income (expense)00(0)(2)2 (5)
Interest and debt expense(0)(0)   (3)(4)
Other undisclosed income from continuing operations before equity method investments, income taxes00 27   
Income (loss) from continuing operations before equity method investments, income taxes:(25)(31)(12)14(12)(15)(12)
Loss from equity method investments (0)(0)    
Other undisclosed income (loss) from continuing operations before income taxes  0(27)   
Loss from continuing operations before income taxes:(25)(31)(12)(14)(12)(15)(12)
Income tax expense (benefit)   2(0)  
Loss from continuing operations:(25)(31)(12)(12)(12)(15)(12)
Loss from discontinued operations  (1)(4)   
Loss before gain (loss) on sale of properties:(25)(31)(13)(16)(12)(15)(12)
Other undisclosed net income 0     
Net loss:(25)(31)(13)(16)(12)(15)(12)
Other undisclosed net loss attributable to parent     (1)(2)
Net loss attributable to parent:(25)(31)(13)(16)(12)(16)(14)
Preferred stock dividends and other adjustments    (4)(3) 
Net loss available to common stockholders, diluted:(25)(31)(13)(16)(16)(19)(14)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(25)(31)(13)(16)(12)(15)(12)
Comprehensive loss, net of tax, attributable to parent:(25)(31)(13)(16)(12)(15)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: